EQUITY RESEARCH MEMO

Pulmodyne

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)55/100

Pulmodyne is a privately held medical device manufacturer based in Indianapolis, specializing in disposable airway and respiratory management products for acute care, emergency/prehospital, and homecare markets. Founded in 2007, the company offers a portfolio of intuitive devices including manual resuscitators, CPAP systems, atomization devices, and emergency surgical airway kits. Pulmodyne operates in a competitive but fragmented market, benefiting from rising respiratory disease prevalence and growing demand for emergency preparedness. While the company lacks publicly available financial data, its focus on rapid-administration design positions it for steady adoption in hospital and prehospital settings. Near-term growth is likely driven by product line extensions and strategic partnerships to expand distribution. Given the private nature, direct investment opportunities are limited; however, monitoring regulatory clearances and commercial agreements can provide insight into market traction.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) Clearance for Next-Generation Disposable CPAP System70% success
  • Q4 2026Exclusive Distribution Agreement with Major National Hospital Group60% success
  • Q2 2026Launch of Enhanced Emergency Surgical Airway Kit80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)